A multicenter study of niraparib as maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer (Polo trial)

被引：0
|
作者：
Kim, Se Ik [1 ]
Choi, Chel Hun [2 ]
Kim, Ji Hyun [3 ,4 ]
Lee, Yong Jae [5 ]
Park, Jeong-Yeol [6 ]
Suh, Dong Hoon [7 ]
Kim, Yong Beom [7 ]
Lee, Jung-Yun [5 ]
Lim, Myong Cheol [3 ,4 ]
Kim, Byoung Gie [2 ]
Kim, Jae-Weon [1 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea
[2] Sungkyunkwan Univ, Dept Obstet & Gynecol, Sch Med, Samsung Med Ctr, Seoul, South Korea
[3] Natl Canc Ctr, Ctr Gynecol Canc, Goyang Si, South Korea
[4] Ctr Clin Trial, Goyang Si, South Korea
[5] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Dept Obstet & Gynecol, Seoul, South Korea
[6] Asan Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[7] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam Si, South Korea
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期
关键词：
D O I：
10.1136/ijgc-2023-IGCS.476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TP016
引用
收藏
页码：A252 / A252
页数：1
相关论文
共 50 条
  • [1] A MULTICENTER STUDY OF NIRAPARIB MAINTENANCE THERAPY IN BRCA WILD-TYPE, NEWLY DIAGNOSED ADVANCED OVARIAN CANCER: POLO TRIAL
    Kim, Se Ik
    Lee, Jung-Yun
    Kim, Byoung-Gie
    Choi, Chel Hun
    Park, Jeong-Yeol
    Lim, Myong Cheol
    Kim, Jae-Weon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A236 - A237
  • [2] First evidence of olaparib maintenance therapy in patients with newly diagnosed BRCA wild-type ovarian cancer: A real-world multicenter study
    Li, J.
    Youguo, C.
    Mian, H.
    Chen, X.
    Wen, H.
    Kang, Y.
    Liu, K. J.
    Lou, G.
    Wang, X.
    Wen, Q. L.
    Wang, L.
    Lin, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1594 - S1595
  • [3] Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
    Kim, Ji Hyun
    Kim, Se Ik
    Park, Eun Young
    Kim, Eun Taeg
    Kim, Hyesu
    Kim, Sangeon
    Park, Sang-Yoon
    Lim, Myong Cheol
    GYNECOLOGIC ONCOLOGY, 2024, 181 : 33 - 39
  • [4] First evidence of olaparib maintenance therapy in patients with newly diagnosed homologous recombination deficient positive/BRCA wild-type ovarian cancer: real-world multicenter study
    Li, Jing
    Chen, Youguo
    He, Mian
    Chen, Xiaoxiang
    Wen, Hao
    Kang, Yu
    Liu, Kaijiang
    Lou, Ge
    Wang, Xipeng
    Wen, Qinglian
    Wang, Li
    Lin, Zhongqiu
    FRONTIERS OF MEDICINE, 2024, 18 (06) : 1026 - 1034
  • [5] Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer A Phase 3 Randomized Clinical Trial
    Li, Ning
    Zhu, Jianqing
    Yin, Rutie
    Wang, Jing
    Pan, Lingya
    Kong, Beihua
    Zheng, Hong
    Liu, Jihong
    Wu, Xiaohua
    Wang, Li
    Huang, Yi
    Wang, Ke
    Zou, Dongling
    Zhao, Hongqin
    Wang, Chunyan
    Lu, Weiguo
    Lin, An
    Lou, Ge
    Li, Guiling
    Qu, Pengpeng
    Yang, Hongying
    Zhang, Yu
    Cai, Hongbing
    Pan, Yueyin
    Hao, Min
    Liu, Ziling
    Cui, Heng
    Yang, Yingjie
    Yao, Shuzhong
    Zhen, Xiaoa
    Hang, Wenzhao
    Hou, Jianmei
    Wang, Juan
    Wu, Lingying
    JAMA ONCOLOGY, 2023, 9 (09) : 1230 - 1237
  • [6] Niraparib maintenance in newly diagnosed advanced ovarian cancer - review and case series
    Tyszka, Martyna
    Stec, Rafal
    ONCOLOGY IN CLINICAL PRACTICE, 2023, 19 (06): : 413 - 418
  • [7] Real-world experience of niraparib as maintenance therapy in newly diagnosed advanced ovarian cancer: A singlecenter retrospective study
    Wenxin, L.
    Wang, K.
    Zhang, L.
    Ma, Y.
    Wu, H.
    Chen, Y.
    Bao, L.
    Fu, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S1594 - S1594
  • [8] Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Gonzalez-Martin, A.
    Pothuri, B.
    Vergote, I.
    DePont Christensen, R.
    Graybill, W.
    Mirza, M. R.
    McCormick, C.
    Lorusso, D.
    Hoskins, P.
    Freyer, G.
    Baumann, K.
    Jardon, K.
    Redondo, A.
    Moore, R. G.
    Vulsteke, C.
    O'Cearbhaill, R. E.
    Lund, B.
    Backes, F.
    Barretina-Ginesta, P.
    Haggerty, A. F.
    Rubio-Perez, M. J.
    Shahin, M. S.
    Mangili, G.
    Bradley, W. H.
    Bruchim, I.
    Sun, K.
    Malinowska, I. A.
    Li, Y.
    Gupta, D.
    Monk, B. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25): : 2391 - 2402
  • [9] Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
    Van Le, Linda
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (01) : 29 - 31
  • [10] IMPACT OF INITIATION TIMING OF NIRAPARIB MAINTENANCE TREATMENT IN NEWLY DIAGNOSED ADVANCED OVARIAN CANCER
    Wang, Jing
    Wu, Lingying
    Zhu, Jianqing
    Yin, Rutie
    Pan, Lingya
    Kong, Beihua
    Zheng, Hong
    Liu, Jihong
    Wu, Xiaohua
    Wang, Li
    Huang, Yi
    Wang, Ke
    Zou, Dongling
    Zhao, Hongqin
    Wang, Chunyan
    Lu, Weiguo
    Lin, An
    Zhen, Xiaoa
    Hang, Wenzhao
    Hou, Jianmei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A174 - A175
12345